Summary Biomedicine AI to predict dementia. Scientists are using AI to analyse 1.6 million brain scans to develop predictive tools for dementia. The aim is to create digital tools that radiologists can use to determine their risk of dementia and diagnose the disease earlier. The obesity drug Wegovy prevents deaths from Covid. People who […]
Summary Biomedicine Brain implants to reduce Parkinson’s symptoms. Implants reduce Parkinson’s symptoms by reading brain activity. Parkinson’s is known to affect about 10 million patients globally. This approach, called deep brain stimulation (DBS), reduces Parkinson’s motor symptoms by half. Global Health The need for international coordination on Mpox. Editorial from The Lancet. 15 months […]
Summary Biomedicine The Lancet provides a clinical update on persistent covid. Defined as symptoms that persist for more than three months. Although the approach is based on symptoms, work is being done on identifying the molecular profile and biomarkers. There is no benefit for adults who drink alcohol in moderation. A long study shows […]
Summary Biomedicine How to reduce the risk of dementia. A healthy lifestyle can prevent or delay at least half of cases. The Lancet article adds two risk factors to the 12 already identified in 2020: untreated vision loss and high cholesterol levels. Modifiable factors include tobacco, obesity, physical inactivity, high blood pressure, diabetes and […]
Summary Biomedicine 14 critical risk factors for developing dementia identified. High cholesterol and hearing problems are associated with the development of dementia, according to a large study, which also identifies 14 critical risk factors that, if reduced, can prevent or delay half of the cases. The FDA approves a test for the detection of colon […]
Summary Biomedicine Keys to a possible cure for AIDS. The 25th International AIDS Conference opened on July 22. Nearly 40 million people are now infected, there were 1.3 million new infections in 2023 and 630,000 AIDS-related deaths, compared with 2.1 million and 1.3 million in 2010, the reference year. Although there is no treatment, […]
Summary Biomedicine The benefits of GLP-1 medications, beyond obesity. These medications may be useful in a wide variety of chronic conditions. There are multiple clinical trials underway. The next decade is likely to allow for greater potential for GLP-1 drugs. The fertility industry. Economic factors are delaying couples’ willingness to have children, which produces […]
Summary Biomedicine Four decades of orphan drugs. The Orphan Drug Act (ODA) was approved in the USA in 1983, due to the lack of commercial interest in the development of these drugs. The law that developed incentives for production, the duration of patents and research was a success and more than 800 indications have already […]
Summary Biomedicine Anniversary of IVF. The first in vitro baby turns forty years old, with the technique becoming the new normal. After 40 years of development and 12 million children born thanks to it, the technique has reached maturity, with less invasive techniques, more effective procedures and a change in the patient profile. “Common […]
Summary Biomedicine Advances in gene editing. Discovery of a new way to program DNA recombination. This increases the possibilities of the current CRISPR editing method. The new route is called the bridge RNA method. Lifestyles can compensate for genetics. Lifestyles can improve genetics by 60% and add 5 years to life. Global Health Loneliness […]
